1. Home
  2. CPIX vs KOSS Comparison

CPIX vs KOSS Comparison

Compare CPIX & KOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPIX
  • KOSS
  • Stock Information
  • Founded
  • CPIX 1999
  • KOSS 1953
  • Country
  • CPIX United States
  • KOSS United States
  • Employees
  • CPIX N/A
  • KOSS N/A
  • Industry
  • CPIX Biotechnology: Pharmaceutical Preparations
  • KOSS Consumer Electronics/Appliances
  • Sector
  • CPIX Health Care
  • KOSS Consumer Staples
  • Exchange
  • CPIX Nasdaq
  • KOSS Nasdaq
  • Market Cap
  • CPIX 68.7M
  • KOSS 59.3M
  • IPO Year
  • CPIX 2009
  • KOSS N/A
  • Fundamental
  • Price
  • CPIX $4.73
  • KOSS $5.14
  • Analyst Decision
  • CPIX
  • KOSS
  • Analyst Count
  • CPIX 0
  • KOSS 0
  • Target Price
  • CPIX N/A
  • KOSS N/A
  • AVG Volume (30 Days)
  • CPIX 44.3K
  • KOSS 118.6K
  • Earning Date
  • CPIX 08-05-2025
  • KOSS 05-08-2025
  • Dividend Yield
  • CPIX N/A
  • KOSS N/A
  • EPS Growth
  • CPIX N/A
  • KOSS N/A
  • EPS
  • CPIX N/A
  • KOSS N/A
  • Revenue
  • CPIX $41,083,299.00
  • KOSS $12,433,361.00
  • Revenue This Year
  • CPIX N/A
  • KOSS N/A
  • Revenue Next Year
  • CPIX N/A
  • KOSS N/A
  • P/E Ratio
  • CPIX N/A
  • KOSS N/A
  • Revenue Growth
  • CPIX 5.82
  • KOSS N/A
  • 52 Week Low
  • CPIX $1.04
  • KOSS $3.81
  • 52 Week High
  • CPIX $7.25
  • KOSS $18.73
  • Technical
  • Relative Strength Index (RSI)
  • CPIX 50.35
  • KOSS 46.52
  • Support Level
  • CPIX $5.11
  • KOSS $4.63
  • Resistance Level
  • CPIX $5.88
  • KOSS $6.16
  • Average True Range (ATR)
  • CPIX 0.41
  • KOSS 0.39
  • MACD
  • CPIX -0.05
  • KOSS -0.13
  • Stochastic Oscillator
  • CPIX 37.67
  • KOSS 33.33

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About KOSS Koss Corporation

Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-canceling headphones. The majority of the firm's revenue is derived from sales of stereo headphones.

Share on Social Networks: